← Insider buys

PAHC

Phibro Animal Health Corporation · Healthcare

Insiders bought $318K of Phibro Animal Health Corporation in the last 12 months

1 insider bought on 1 day.

$318KBought, 12 mo
$24.1MSold, 12 mo
$1.6BMarket cap

PAHC over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

PAHC after insider buys

3 months after each buy, from the first price a copier could get.

+17.2%Average
+12.8 ptsVs S&P 500
3 of 3Higher

3 buys since 2019 with 3 months of prices.

Every filing

148 insider filings since 2016, newest first

PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.4M−50.0%Jul 11
PAHCSell

Bfi Co., LLC · 10% owner

$1.4M−50.0%Jul 11
PAHCSell

Dean J Warras · Pres Animal Health, Nutr N.A.

$464K−100.0%Jul 5
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.4M−50.0%Jun 29
PAHCSell

Bfi Co., LLC · 10% owner

$1.4M−50.0%Jun 29
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.4M−50.0%Jun 21
PAHCSell

Bfi Co., LLC · 10% owner

$1.4M−50.0%Jun 21
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.4M−50.0%Jun 13
PAHCSell

Bfi Co., LLC · 10% owner

$1.4M−50.0%Jun 13
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.4M−52.0%Jun 7
PAHCSell

Bfi Co., LLC · 10% owner

$1.4M−52.0%Jun 7
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$117K−4.0%May 29
PAHCSell

Bfi Co., LLC · 10% owner

$117K−4.0%May 29
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$117K−4.0%May 25
PAHCSell

Bfi Co., LLC · 10% owner

$117K−4.0%May 25
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$447K−83.0%May 22
PAHCSell

Bfi Co., LLC · 10% owner

$447K−83.0%May 22
PAHCSell

Bfi Co., LLC · 10% owner

$961K−67.0%Mar 16
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$961K−67.0%Mar 16
PAHCSell

Daniel M Bendheim · EVP, Corporate Strategy

$927K−100.0%Mar 12
PAHCSell

Bfi Co., LLC · 10% owner

$1.4M−50.0%Mar 7
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.4M−50.0%Mar 7
PAHCSell

Daniel M Bendheim · EVP, Corporate Strategy

$159K−100.0%Mar 7
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.4M−50.0%Mar 1
PAHCSell

Bfi Co., LLC · 10% owner

$1.4M−50.0%Mar 1
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$565K−41.0%Feb 26
PAHCSell

Bfi Co., LLC · 10% owner

$565K−41.0%Feb 26
PAHCSell

Larry Lee Miller · COO

$631K−100.0%Feb 15
PAHCSell

Larry Lee Miller · COO

$1.9M−100.0%Feb 13
PAHCSell

Dean J Warras · Pres Animal Health, Nutr N.A.

$356K−100.0%Feb 13
PAHCSell

Dean J Warras · Pres Animal Health, Nutr N.A.

$357K−100.0%Sep 20
PAHCSell

Richard G Johnson · CFO

$2.0M−100.0%Sep 15
PAHCSell

Larry Lee Miller · COO

$781K−100.0%Sep 15
PAHCSell

Larry Lee Miller · COO

$1.7M−100.0%Sep 12
PAHCSell

Richard G Johnson · CFO

$1.7M−100.0%Sep 12
PAHCSell

Gerald K Carlson · Director

$196K−100.0%Sep 12
PAHCSell

Larry Lee Miller · COO

$1.2M−100.0%Sep 7
PAHCSell

Richard G Johnson · CFO

$1.1M−100.0%Sep 7
PAHCSell

Daniel M Bendheim · EVP, Corporate Strategy

$199K−100.0%Aug 21
PAHCSell

Daniel M Bendheim · EVP, Corporate Strategy

$308K−100.0%Aug 16
PAHCSell

Bfi Co., LLC · 10% owner

$1.2M−73.0%Jul 7
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.2M−73.0%Jul 7
PAHCSell

Bfi Co., LLC · 10% owner

$1.8M−52.0%Jun 30
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.8M−52.0%Jun 30
PAHCSell

Bfi Co., LLC · 10% owner

$1.8M−50.0%Jun 23
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.8M−50.0%Jun 23
PAHCSell

Bfi Co., LLC · 10% owner

$1.7M−50.0%Jun 15
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.7M−50.0%Jun 15
PAHCSell

Bfi Co., LLC · 10% owner

$1.7M−50.0%Jun 9
PAHCSell

Jack Bendheim · President, CEO and 10% owner

$1.7M−50.0%Jun 9
About Phibro Animal Health Corporation

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.